Here we modulated Shp2 expression using intravitreal AAV administration and studied its impact on the retina using a combination of functional, biochemical and anatomical changes in the WT and Cav-1-/- mice under normal physiological and experimental glaucoma conditions. The gene discussed is CAV1; the disease is glaucoma.